Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 6Active not recruiting 6Unknown 4Terminated 4Recruiting 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other 1Gastrointestinal 1

Conditions

Radiation Fibrosis Syndrome 1Pancreatic Neoplasms 1Lung Neoplasms 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Losartan × Clear all
NCT05861336 2024-12-27

OVERPASS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00880386 2017-05-02

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

University of South Florida

Phase NA Withdrawn
OtherThoracic

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡